XADAGO

This brand name is authorized in Austria, Australia, Brazil, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Turkey, United Kingdom, United States

Active ingredients

The drug XADAGO contains one active pharmaceutical ingredient (API):

1 Safinamide UNII YS90V3DTX0 - SAFINAMIDE MESYLATE

Safinamide acts through both dopaminergic and non-dopaminergic mechanisms of action. Safinamide is a highly selective and reversible MAO-B inhibitor causing an increase in extracellular levels of dopamine in the striatum. Safinamide is indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as addon therapy to a stable dose of levodopa (L-dopa). Read about Safinamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XADAGO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04BD03		N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BD Monoamine oxidase B inhibitors
Discover more medicines within N04BD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11656L, 11666B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 533819020009002, 533819020009102, 533819020009202, 533819020009302, 533819020009402
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10937995, 10938026, 10938032, 10938049
Country: EE	Ravimiamet	Identifier(s): 1677810, 1677821, 1677832, 1677843, 1677854, 1677865, 1677876, 1677887, 1677898, 1677900
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114984003, 114984003IP, 114984008, 114984008IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 047943, 106219, 542507, 545736
Country: FR	Base de données publique des médicaments	Identifier(s): 61882445, 66932795
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 325049, 325052
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8885, 8886
Country: IT	Agenzia del Farmaco	Identifier(s): 043906015, 043906027, 043906039, 043906041, 043906054, 043906066, 043906078, 043906080, 043906092, 043906104
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075828, 1075829, 1075830, 1075831, 1075832, 1075833, 1075834, 1075835, 1075836, 1075837
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 130745, 130753
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100338977, 100338983
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699769090227, 8699769090234
Country: US	FDA, National Drug Code	Identifier(s): 27505-110, 27505-111